NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析

◆英語タイトル:NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3594142FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NeuroScientific Biopharmaceuticals Ltd (NSB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroScientific Biopharmaceuticals Ltd (NeuroScientific) develops novel pharmaceutical products that target neurological disorders which have high unmet medical needs. The company’s pipeline products include EmtinB therapeutic peptide which is being developed for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s Disease and degenerative conditions of the optic nerve. The company has partnerships with various institute such as Lion’s Eye Institute, and Menzies Institute for Medical Research among others for research and the development of its pipeline product. NeuroScientific is headqutered in Nedlands, Western Australia, Australia.

NeuroScientific Biopharmaceuticals Ltd Key Recent Developments

Sep 25,2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25,2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30,2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NeuroScientific Biopharmaceuticals Ltd – Key Facts
NeuroScientific Biopharmaceuticals Ltd – Key Employees
NeuroScientific Biopharmaceuticals Ltd – Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd – Major Products and Services
NeuroScientific Biopharmaceuticals Ltd – History
NeuroScientific Biopharmaceuticals Ltd – Company Statement
NeuroScientific Biopharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
NeuroScientific Biopharmaceuticals Ltd – Business Description
NeuroScientific Biopharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
NeuroScientific Biopharmaceuticals Ltd – Strengths
NeuroScientific Biopharmaceuticals Ltd – Weaknesses
NeuroScientific Biopharmaceuticals Ltd – Opportunities
NeuroScientific Biopharmaceuticals Ltd – Threats
NeuroScientific Biopharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30, 2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NeuroScientific Biopharmaceuticals Ltd, Key Facts
NeuroScientific Biopharmaceuticals Ltd, Key Employees
NeuroScientific Biopharmaceuticals Ltd, Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd, Major Products and Services
NeuroScientific Biopharmaceuticals Ltd, History
NeuroScientific Biopharmaceuticals Ltd, Key Competitors
NeuroScientific Biopharmaceuticals Ltd, Ratios based on current share price
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios (Cont...1)
NeuroScientific Biopharmaceuticals Ltd, Interim Ratios
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carso Infraestructura y Construccion SA De CV:企業の戦略・SWOT・財務情報
    Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report Summary Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Brioche Pasquier S.A.:企業の戦略・SWOT・財務分析
    Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report Summary Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MILEI GmbH:戦略・SWOT・企業財務分析
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cenovus Energy Inc (CVE)-石油・ガス分野:企業M&A・提携分析
    Summary Cenovus Energy Inc (Cenovus Energy) is an oil and gas company, which explores, develops and produces crude oil and natural gas. The company also carries out processing of natural gas liquids. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves. Its project …
  • Fibrocell Science Inc (FCSC):医療機器:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • PolyPid Ltd (POLY):製薬・医療:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Bombardier Inc:企業の戦略・SWOT・財務情報
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Chongqing Rural Commercial Bank Co., Ltd.:戦略・SWOT・企業財務分析
    Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Sequana SA (SEQ):企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nurix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Enel Americas S.A. (ENELAM):電力:M&Aディール及び事業提携情報
    Summary Enel Americas S.A. (Enel Americas), formerly Enersis Americas S.A., is an integrated electricity utility in Latin America. The group through its subsidiaries and affiliates carries out the generation, transmission and distribution of electricity in Argentina, Brazil, Colombia and Peru. Enel …
  • QEP Resources, Inc. (QEP):石油・ガス:M&Aディール及び事業提携情報
    Summary QEP Resources Inc (QEP) is an independent oil and natural gas exploration and production company. It has operating interests in Northern Region chiefly in North Dakota, Wyoming and Utah; and Southern Region essentially in Texas and Louisiana. In Northern Region, the company owns productive w …
  • Ethypharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethypharm SA (Ethypharm), a subsidiary of Astorg Partners is a pharmaceutical company that develops and manufactures drugs for the treatment of pain, gastrointestinal, cancer, cardiovascular and central nervous system diseases. The company provides products such as ibuprofen, paracetamol, pr …
  • Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pengrowth Energy Corp (Pengrowth) is an oil and gas company that explores, acquires, develops and produces oil and natural gas reserves. The company's services include development of large accu …
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆